FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980592020> ?p ?o ?g. }

• W2980592020 endingPage "e100091" @default.
• W2980592020 startingPage "e100091" @default.
• W2980592020 abstract "Background Hyperprolactinaemia is a common antipsychotic (AP)-induced adverse effect, particularly in female patients. Aims This meta-analysis examined the efficacy and safety of adjunctive aripiprazole in preventing AP-related hyperprolactinaemia in patients with first-episode schizophrenia. Methods PubMed, PsycINFO, EMBASE, Cochrane Library, WanFang and China Journal Net databases were searched to identify eligible randomised controlled trials (RCTs). Primary outcomes were the reductions of serum prolactin level and prolactin-related symptoms. Data were independently extracted by two reviewers and analysed using RevMan (V.5.3). Weighted/standardised mean differences (WMDs/SMDs)±95% CIs were reported. Results In the five RCTs (n=400), the adjunctive aripiprazole (n=197) and the control groups (n=203) with a mean of 11.2 weeks of treatment duration were compared. The aripiprazole group had a significantly lower endpoint serum prolactin level in all patients (five RCTs, n=385; WMD: −50.43 ng/mL (95% CI: −75.05 to −25.81), p<0.00001; I 2 =99%), female patients (two RCTs, n=186; WMD: −22.58 ng/mL (95% CI: −25.67 to −19.49), p<0.00001; I 2 =0%) and male patients (two RCTs, n=127; WMD: −68.80 ng/mL (95% CI: −100.11 to −37.49), p<0.0001). In the sensitivity analysis for the endpoint serum prolactin level in all patients, the findings remained significant (p<0.00001; I 2 =96%). The aripiprazole group was superior to the control group in improving negative symptoms as assessed by the Positive and Negative Syndrome Scale (three RCTs, n=213; SMD: −0.51 (95% CI: −0.79 to −0.24), p=0.0002; I 2 =0%). Adverse effects and discontinuation rates were similar between the two groups. Conclusions Adjunctive aripiprazole appears to be associated with reduced AP-induced hyperprolactinaemia and improved prolactin-related symptoms in first-episode schizophrenia. Further studies with large sample sizes are needed to confirm these findings." @default.
• W2980592020 created "2019-10-25" @default.
• W2980592020 creator A5003157691 @default.
• W2980592020 creator A5007207770 @default.
• W2980592020 creator A5013487786 @default.
• W2980592020 creator A5016681255 @default.
• W2980592020 creator A5053005249 @default.
• W2980592020 creator A5067492834 @default.
• W2980592020 creator A5084342670 @default.
• W2980592020 creator A5087156370 @default.
• W2980592020 creator A5091303329 @default.
• W2980592020 date "2019-10-01" @default.
• W2980592020 modified "2023-10-05" @default.
• W2980592020 title "Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis" @default.
• W2980592020 cites W1247968195 @default.
• W2980592020 cites W1439442567 @default.
• W2980592020 cites W1480729244 @default.
• W2980592020 cites W1598602811 @default.
• W2980592020 cites W1971179661 @default.
• W2980592020 cites W1986215651 @default.
• W2980592020 cites W1992457778 @default.
• W2980592020 cites W2005501262 @default.
• W2980592020 cites W2009832071 @default.
• W2980592020 cites W2020844317 @default.
• W2980592020 cites W2024672351 @default.
• W2980592020 cites W2033361945 @default.
• W2980592020 cites W2034248127 @default.
• W2980592020 cites W2038693293 @default.
• W2980592020 cites W2057190938 @default.
• W2980592020 cites W2073639928 @default.
• W2980592020 cites W2081752752 @default.
• W2980592020 cites W2105507333 @default.
• W2980592020 cites W2107328434 @default.
• W2980592020 cites W2126930838 @default.
• W2980592020 cites W2127750886 @default.
• W2980592020 cites W2135400982 @default.
• W2980592020 cites W2138174562 @default.
• W2980592020 cites W2140606211 @default.
• W2980592020 cites W2157823046 @default.
• W2980592020 cites W2165010366 @default.
• W2980592020 cites W2166604754 @default.
• W2980592020 cites W2166770851 @default.
• W2980592020 cites W2172047405 @default.
• W2980592020 cites W2268045776 @default.
• W2980592020 cites W2300801831 @default.
• W2980592020 cites W2395658557 @default.
• W2980592020 cites W2410507371 @default.
• W2980592020 cites W2515404667 @default.
• W2980592020 cites W2531567495 @default.
• W2980592020 cites W2534300401 @default.
• W2980592020 cites W2604943251 @default.
• W2980592020 cites W2899390983 @default.
• W2980592020 cites W2899731875 @default.
• W2980592020 cites W4254230094 @default.
• W2980592020 doi "https://doi.org/10.1136/gpsych-2019-100091" @default.
• W2980592020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6802974" @default.
• W2980592020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31673677" @default.
• W2980592020 hasPublicationYear "2019" @default.
• W2980592020 type Work @default.
• W2980592020 sameAs 2980592020 @default.
• W2980592020 citedByCount "8" @default.
• W2980592020 countsByYear W29805920202020 @default.
• W2980592020 countsByYear W29805920202021 @default.
• W2980592020 countsByYear W29805920202022 @default.
• W2980592020 countsByYear W29805920202023 @default.
• W2980592020 crossrefType "journal-article" @default.
• W2980592020 hasAuthorship W2980592020A5003157691 @default.
• W2980592020 hasAuthorship W2980592020A5007207770 @default.
• W2980592020 hasAuthorship W2980592020A5013487786 @default.
• W2980592020 hasAuthorship W2980592020A5016681255 @default.
• W2980592020 hasAuthorship W2980592020A5053005249 @default.
• W2980592020 hasAuthorship W2980592020A5067492834 @default.
• W2980592020 hasAuthorship W2980592020A5084342670 @default.
• W2980592020 hasAuthorship W2980592020A5087156370 @default.
• W2980592020 hasAuthorship W2980592020A5091303329 @default.
• W2980592020 hasBestOaLocation W29805920201 @default.
• W2980592020 hasConcept C118552586 @default.
• W2980592020 hasConcept C126322002 @default.
• W2980592020 hasConcept C168563851 @default.
• W2980592020 hasConcept C197934379 @default.
• W2980592020 hasConcept C203092338 @default.
• W2980592020 hasConcept C2776412080 @default.
• W2980592020 hasConcept C2776478404 @default.
• W2980592020 hasConcept C2779064019 @default.
• W2980592020 hasConcept C2780211496 @default.
• W2980592020 hasConcept C2780494398 @default.
• W2980592020 hasConcept C2781401123 @default.
• W2980592020 hasConcept C71315377 @default.
• W2980592020 hasConcept C71924100 @default.
• W2980592020 hasConcept C95190672 @default.
• W2980592020 hasConceptScore W2980592020C118552586 @default.
• W2980592020 hasConceptScore W2980592020C126322002 @default.
• W2980592020 hasConceptScore W2980592020C168563851 @default.
• W2980592020 hasConceptScore W2980592020C197934379 @default.
• W2980592020 hasConceptScore W2980592020C203092338 @default.
• W2980592020 hasConceptScore W2980592020C2776412080 @default.
• W2980592020 hasConceptScore W2980592020C2776478404 @default.
• W2980592020 hasConceptScore W2980592020C2779064019 @default.

• next